Related Experiment Videos
Evaluation of treatment-resistant schizophrenia
1Maryland Psychiatric Research Ctr., Baltimore, MD 21228, USA.
Schizophrenia Bulletin
|January 1, 1997
Summary
Evaluating treatment resistance in schizophrenia is crucial with new antipsychotics. Understanding medication trials and target symptoms helps clinicians manage treatment-resistant schizophrenia effectively.
Area of Science:
- Psychiatry and Pharmacology
Background:
- The introduction of novel antipsychotics necessitates a systematic approach to evaluating treatment resistance in schizophrenia.
- Accurate assessment is vital for optimizing patient outcomes.
Purpose of the Study:
- To highlight the importance of evaluating treatment resistance in schizophrenia.
- To guide clinicians in managing patients with treatment-resistant schizophrenia.
Main Methods:
- Review of current clinical practices and literature regarding antipsychotic medication trials.
- Analysis of factors contributing to poor treatment response in schizophrenia.
Main Results:
- Treatment resistance in schizophrenia can stem from medication intolerance, poor compliance, incorrect dosing, or true illness resistance.
- Defining appropriate trial lengths and target symptoms is key.
Conclusions:
- A systematic evaluation framework is essential for identifying and managing treatment-resistant schizophrenia.
- Clinicians need clear guidelines on antipsychotic trial duration and symptom response to improve patient care.